Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cancer Science|February 27, 2016
Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinomaChaoya Ma, Yoshihiro Komohara, Koji Ohnishi, et al.
Cancer Science|November 3, 2023
Dysfunction of sinus macrophages in tumor-bearing host induces resistance to immunotherapyToshiki Anami, Cheng Pan, Yukio Fujiwara, et al.
Current Issues in Molecular Biology|December 27, 2024
ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell CarcinomaJinglong Tang, Shintaro Funasaki, Hidekazu Nishizawa, et al.
Cancer Science|April 9, 2022
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugateShintaro Funasaki, Sally Mehanna, Wenjuan Ma, et al.
International Journal of Clinical Oncology|August 20, 2025
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in JapanToshiki Anami, Takanobu Motoshima, Yuto Matsushita, et al.
Oncology Research|January 12, 2022
STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell CarcinomaKazuhiro Yamamoto, Takeshi Ioroi, Kazuaki Shinomiya, et al.
World Journal of Urology|September 26, 2024
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapyKazutoshi Fujita, Yuto Matsushita, Shingo Toyoda, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 14, 2025
HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid SynthesisHidekazu Nishizawa, Shintaro Funasaki, Wenjuan Ma, et al.
Clinical Genitourinary Cancer|May 7, 2024
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world DataRyotaro Tomida, Masayuki Takahashi, Yuto Matsushita, et al.
JCO Clinical Cancer Informatics|April 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC StudyMasaki Shiota, Shota Nemoto, Ryo Ikegami, et al.
Pageof 5